Osterweis Capital Management Inc Invitae Corp Transaction History

Osterweis Capital Management Inc

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2019 Feb 14, 2020	SELL	$15.02 - $20.57 $2.03 Million - $2.78 Million	-134,925 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$18.85 - $27.5 $2.54 Million - $3.71 Million	134,925 New	134,925 $2.6 Million

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Osterweis Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Osterweis Capital Management Inc with notifications on news.